Joel Isaacson & Co. LLC Boosts Holdings in UnitedHealth Group Incorporated $UNH

Joel Isaacson & Co. LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 47.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,574 shares of the healthcare conglomerate’s stock after purchasing an additional 2,770 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in UnitedHealth Group were worth $2,961,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group in the second quarter worth $25,000. Sagard Holdings Management Inc. bought a new stake in UnitedHealth Group in the 2nd quarter worth approximately $29,000. Grey Fox Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth $33,000. Islay Capital Management LLC bought a new position in UnitedHealth Group in the second quarter valued at about $31,000. Finally, Riggs Asset Managment Co. Inc. grew its stake in shares of UnitedHealth Group by 69.4% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 43 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $338.47 on Wednesday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The stock has a 50 day moving average of $330.76 and a 200 day moving average of $322.56. The firm has a market cap of $306.60 billion, a PE ratio of 17.67, a PEG ratio of 2.00 and a beta of 0.42.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the prior year, the company earned $7.15 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analyst Ratings Changes

A number of analysts have commented on the stock. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Wednesday, October 29th. Evercore ISI raised UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Finally, UBS Group raised their price target on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $385.75.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.